Call Options

12 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2022

May 17, 2022

SELL
$9.94 - $12.65 $422,450 - $537,625
-42,500 Reduced 29.35%
102,300 $1.24 Million
Q4 2021

Feb 15, 2022

BUY
$11.99 - $18.14 $268,576 - $406,336
22,400 Added 18.3%
144,800 $1.76 Million
Q3 2021

Nov 16, 2021

BUY
$11.55 - $16.06 $531,300 - $738,759
46,000 Added 60.21%
122,400 $1.89 Million
Q2 2021

Aug 16, 2021

SELL
$12.38 - $29.19 $133,704 - $315,252
-10,800 Reduced 12.39%
76,400 $1.09 Million
Q1 2021

May 18, 2021

BUY
$15.07 - $21.71 $55,759 - $80,327
3,700 Added 4.43%
87,200 $1.89 Million
Q4 2020

Feb 17, 2021

BUY
$12.72 - $16.16 $686,880 - $872,640
54,000 Added 183.05%
83,500 $1.26 Million
Q3 2020

Nov 17, 2020

SELL
$12.34 - $17.92 $1.19 Million - $1.73 Million
-96,600 Reduced 76.61%
29,500 $375,000
Q2 2020

Aug 17, 2020

BUY
$12.39 - $17.33 $1.56 Million - $2.19 Million
126,100 New
126,100 $2.16 Million
Q4 2018

Feb 15, 2019

SELL
$12.45 - $23.47 $120,765 - $227,659
-9,700 Closed
0 $0
Q3 2018

Nov 14, 2018

SELL
$17.57 - $23.95 $513,044 - $699,340
-29,200 Reduced 75.06%
9,700 $232,000
Q2 2018

Aug 15, 2018

BUY
$11.6 - $19.27 $1,160 - $1,927
100 Added 0.26%
38,900 $745,000
Q1 2018

May 15, 2018

BUY
$11.77 - $16.08 $456,676 - $623,903
38,800 New
38,800 $480,000

Others Institutions Holding CARA

About Cara Therapeutics, Inc.


  • Ticker CARA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,725,900
  • Market Cap $16.1M
  • Description
  • Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...
More about CARA
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.